🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

If you have an empty house, we support you to find people that urgently need a home. By using birkirabiryuva.org you can offer a home or provide financial support directly to the citizens affected by the earthquake.

Earthquake in #Türkiye and #Syria: There is an urgent need for winter clothes, tents, food and hygiene items such as sanitary pads. You can help secure essential items for women, girls and their families. Donate now: unwo.men/2Efl50MQgmu

One of Izmir’s sister cities, Tel Aviv - Yafo has made special effort to assist the victims of the earthquake disaster since the first day of the earthquake.

Last Wednesday, on 22nd of February, we have witnessed outstanding solidarity in an outside Türkiye. A tremendous hope arose for earthquake victims from Izmir. I am grateful to all who supported our “OneRentOneHome” campaign.

📢Jefferson county residents: if you are age 45-75 and uninsured/underinsured you may qualify for a free colonoscopy UAB Medicine ! Please see a Cooper Green Primary care provider for a referral! Randall Woodfin Alabama Public Health UAB GI Surgery UAB O'Neal Comprehensive Cancer Center

Please join us in welcoming Zaid Al-Kadhimi, M.D., the new director of the Blood and Marrow Transplantation and Cell Therapy Program, to UAB and the O’Neal Comprehensive Cancer Center. Read more: onealcanceruab.org/news-and-event…

ACCRU GI-2017 hypothesizes that Nivolumab + Ipilimumab will achieve objective response in patients who have progressed radiographically on Atezolizumab and Bevacizumab that necessitates a change in treatment. Read on. buff.ly/3AVfApF #cancerresearch #cancerstudy

Maya Khalil, MD, of UAB O'Neal Comprehensive Cancer Center, discusses key clinical trial updates on the use of nivolumab and ipilimumab with or without chemotherapy in non–small cell lung cancer. #lcsm ow.ly/sNtw50NOEiz

Millet Buluşması #Uşak x.com/i/broadcasts/1…

Vatanını seven sandığa gelir.

Learn about the criteria for enrollment in ACCRU study GI-2017, a Phase II study for patients with HCC. buff.ly/3AVfApF #HCC #HCCSM

ACCRU GI-2017 explores second line treatment options for patients with HCC Hepatocellular Carcinoma. Learn more. buff.ly/3OiZ09G #GI #GISM #GICancer

Looking forward to a great ONeal Hematology Oncology Review UAB O'Neal Comprehensive Cancer Center UAB Hematology/Oncology Fellowship

Long live the Republic of Türkiye!

Last night, Istanbul hosted a spectacular celebration in honor of our Republic’s 100th anniversary 🇹🇷🇹🇷🇹🇷

Excitement of travel to ASCO got tripled after I ran into Mehmet Akce, MD and Grant R. Williams, MD, MSPH, FASCO Talking science en route to Chicago from Alabama Bassel El-Rayes, MD #UAB #onealcomprehensivecancercenter

Forever grateful to Mustafa Kemal Ataturk!

Awesome presentation on rectal cancer management by Midhun Malla at our GI symposium

Frontline and beyond frontline therapeutic options in pancreatic ductal adenocarcinoma. Bassel El-Rayes, MD provides his expert insights on targeted therapeutic approaches with a comprehensive review!! J. Bart Rose UAB O'Neal Comprehensive Cancer Center Mehmet Akce, MD

⭐ In an exclusive interview with GI Oncology Now, Bassel El-Rayes, MD of UAB O'Neal Comprehensive Cancer Center reflects on his career in translational research and his efforts to expand clinical trial infrastructure and foster collaboration: buff.ly/Bz1ou9F